ANIP
ANI Pharmaceuticals, Inc.
$78.53
$1.79B
Price
$78.53
Market Cap
$1.79B
Revenue CAGR (5Y)
+27.7%
EPS CAGR (5Y)
+22.5%
Revenue Growth
Year over Year+68.5%
2016
+37.5%
2017
+14.0%
2018
+2.5%
2019
+0.9%
2020
+3.7%
2021
+46.4%
2022
+53.9%
2023
+26.2%
2024
+43.8%
2025
EPS Growth
Year over Year-74.6%
2016
-127.4%
2017
+1527.0%
2018
-61.7%
2019
-468.6%
2020
-80.9%
2021
+10.3%
2022
+131.1%
2023
-209.5%
2024
+436.5%
2025